Vedolizumab Induced Clinical, Endoscopic, And Histological Improvement In Common Variable Immunodeficiency Disease-Associated Intestinal Enteropathy

Hisham Javed Akhtar, Bharat Markandey,Christopher Ma,Darryl Ramsewak,Joanna C Walsh,Vipul Jairath

INFLAMMATORY BOWEL DISEASES（2020）

引用 7|浏览4

暂无评分

摘要

After treatment with vedolizumab, a patient with diarrhea and malnutrition secondary to common variable immune deficiency (CVID)-related enteropathy was able to achieve clinical, endoscopic, and histological improvement. Vedolizumab may be a treatment option for patients with CVID-associated enteropathy.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要